These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29150865)

  • 21. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction.
    Ponterio G; Faustini G; El Atiallah I; Sciamanna G; Meringolo M; Tassone A; Imbriani P; Cerri S; Martella G; Bonsi P; Bellucci A; Pisani A
    Mov Disord; 2022 May; 37(5):949-961. PubMed ID: 35420219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.
    Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A
    Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.
    Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y
    Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.
    Pappas SS; Darr K; Holley SM; Cepeda C; Mabrouk OS; Wong JM; LeWitt TM; Paudel R; Houlden H; Kennedy RT; Levine MS; Dauer WT
    Elife; 2015 Jun; 4():e08352. PubMed ID: 26052670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
    Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
    Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice.
    D'Angelo V; Giorgi M; Paldino E; Cardarelli S; Fusco FR; Saverioni I; Sorge R; Martella G; Biagioni S; Mercuri NB; Pisani A; Sancesario G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia.
    Sciamanna G; Tassone A; Martella G; Mandolesi G; Puglisi F; Cuomo D; Madeo G; Ponterio G; Standaert DG; Bonsi P; Pisani A
    PLoS One; 2011; 6(9):e24261. PubMed ID: 21912682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2022 Jun; 168():105699. PubMed ID: 35314320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors.
    Ziółkowska B; Urbański MJ; Wawrzczak-Bargieła A; Bilecki W; Przewłocki R
    J Neurosci Res; 2005 Nov; 82(4):563-70. PubMed ID: 16211563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optogenetic augmentation of the hypercholinergic endophenotype in DYT1 knock-in mice induced erratic hyperactive movements but not dystonia.
    Richter F; Bauer A; Perl S; Schulz A; Richter A
    EBioMedicine; 2019 Mar; 41():649-658. PubMed ID: 30819512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals.
    Baillie LD; Schmidhammer H; Mulligan SJ
    Neuropharmacology; 2015 Jun; 93():267-73. PubMed ID: 25721395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesia.
    Scarduzio M; Eskow Jaunarajs KL; Standaert DG
    Neurobiol Dis; 2024 Oct; 201():106685. PubMed ID: 39343248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia.
    Vanni V; Puglisi F; Bonsi P; Ponterio G; Maltese M; Pisani A; Mandolesi G
    Exp Neurol; 2015 Sep; 271():457-67. PubMed ID: 26183317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior.
    Horner KA; Hebbard JC; Logan AS; Vanchipurakel GA; Gilbert YE
    J Neurochem; 2012 Mar; 120(5):779-94. PubMed ID: 22150526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Transgenic Mouse Model to Investigate the Cell-Autonomous Effects of torsinA(ΔE) Expression in Striatal Output Neurons.
    Gonzalez-Alegre P; Beauvais G; Martin J; Koch RJ; Walker RH; Patel JC; Rice ME; Ehrlich ME
    Neuroscience; 2019 Dec; 422():1-11. PubMed ID: 31669362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum.
    Maltese M; Stanic J; Tassone A; Sciamanna G; Ponterio G; Vanni V; Martella G; Imbriani P; Bonsi P; Mercuri NB; Gardoni F; Pisani A
    Elife; 2018 Mar; 7():. PubMed ID: 29504938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The abnormal firing of Purkinje cells in the knockin mouse model of DYT1 dystonia.
    Liu Y; Xing H; Wilkes BJ; Yokoi F; Chen H; Vaillancourt DE; Li Y
    Brain Res Bull; 2020 Dec; 165():14-22. PubMed ID: 32976982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.